Drug susceptibility of fungi isolated from ICU patients

• Autorzy: Modrzewska B.D. , Kurnatowska A.J. , Khalid K.
• Języki publikacji: EN

Abstrakty

EN

Candida species can be a reason of infections associated with high morbidity and mortality. The risk of invasive candidosis for patients admitted to intensive care units (ICUs) is increased due to immunosuppressive states, prolonged length of stay, broad-spectrum antibiotics and Candida colonization. The aim of the study was to determine selected properties of fungi isolated from patients treated in the ICUs of hospitals in Lodz. The materials were collected from the oral cavity, the tracheostomy or endotracheal tube and urine from 16 children and 35 adult. In total, 127 samples were examined to differentiate the fungal strains with used morphological and biochemical methods. Candida species were isolated from adult patients (82.9%), but were not isolated from any of the children; C. albicans was the predominant fungus (61.7%), much less frequent were C. glabrata (12.8%), C. tropicalis (6.4%) and C. kefyr, C. dubliniensis (4.3% each).The susceptibility of fungi to antimycotic drugs revealed that almost all of the strains were susceptible to nystatin (97.9%) and to amphotericin B (72.3%), and resistant to fluconazole (72.3%) and ketoconazole (57.5%). No isolation of fungi from children remaining in ICU may be an evidence of high sanitary regime at these wards; fungi from the genus Candida are the etiological factors for ICU infections; 3/5 of them are caused by C. albicans, mostly of the code 2 576 174, characteristic for strains isolated from hospitalized patients; it is necessary to determine the species of the fungus and its susceptibility to drugs, which allows to conduct effective therapy; prophylactic administration of fluconazole leads to an increase in the number of strains resistant to this chemotherapeutic agent; in the antifungal local treatment, nystatin should be a drug of choice as the drug to which most fungi are susceptible.

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2017
• Tom: 63
• Numer: 3
• Opis fizyczny: p.189-198,ref.

Twórcy

autor

Modrzewska B.D.

• Department of Biology and Medical Parasitology, Medical University of Lodz, Hallera Sq. 1, 90-647 Lodz, Poland

autor

Kurnatowska A.J.

• The Angelus Silesius University of Applied Sciences in Walbrzych, Zamkowa 4, 58-300 Walbrzych, Poland

autor

Khalid K.

• Department of Biology and Medical Parasitology, Medical University of Lodz, Hallera Sq. 1, 90-647 Lodz, Poland

Bibliografia

• [1] Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., Edmond M.B. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases 39: 309-317. https://doi.org/10.1086/421946
• [2] Marchetti O., Bille J., Fluckiger U., Eggimann P., Ruef C., Garbino J., Calandra T., Glauser M.-P., Täuber M.G., Pittet D., Fungal Infection Network of Switzerland (FUNGINOS). 2004. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clinical Infectious Diseases 38: 311-320. https://doi.org/10.1086/380637
• [3] Méan M., Marchetti O., Calandra T. 2008. Bench-tobedside review: Candida infections in the intensive care unit. Critical Care 12: 204. doi:10.1186/cc6212
• [4] Pappas P.G. 2006. Invasive candidiasis. Infectious Disease Clinics of North America 20: 485-506. http://dx.doi.org/10.1016/j.idc.2006.07.004
• [5] Badiee P., Hashemizadeh Z. 2014. Opportunistic invasive fungal infections: diagnosis & clinical management. Indian Journal of Medical Research 139: 195-204.
• [6] León C., Ostrosky-Zeichner L., Schuster M. 2014. What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Medicine 40: 808-819. doi:10.1007/s00134-014-3281-0
• [7] Kurnatowska A., Kurnatowski P. 2006. Mikologia medyczna [Medical mycology]. Promedi, Lodz (in Polish).
• [8] Mahmoudabadi A.Z., Rezaei-Matehkolaei A., Navid M., Torabizadeh M., Mazdarani S. 2015. Colonization and antifungals susceptibility patterns of Candida species isolated from hospitalized patients in ICUs and NICUs. Journal of Nephropathology 4: 77-84. doi:10.12860/jnp.2015.15
• [9] Sutcu M., Salman N., Akturk H., Dalgıc N., Turel O., Kuzdan C., Kadayifci E.K., Sener D., Karbuz A., Erturan Z., Somer A. 2016. Epidemiologic and microbiologic evaluation of nosocomial infections associated with Candida spp. in children: a multicenter study from Istanbul, Turkey. American Journal of Infection Control 44: 1139-1143. http://dx.doi.org/10.1016/j.ajic.2016.03.056
• [10] Gholamipour P., Mahmoudi S., Pourakbari B., Taghi Haghi Ashtiani M., Sabouni F., Teymuri M., Mamishi S. 2014. Candiduria in children: a first report from an Iranian referral pediatric hospital. Journal of Preventive Medicine and Hygiene 55: 54-57. http://dx.doi.org/10.15167/2421-4248/jpmh2014.55. 2.429
• [11] Mesini A., Bandettini R., Caviglia I., Fioredda F., Amoroso L., Faraci M., Mattioli G., Piaggio G., Risso F.M., Moscatelli A., Loy A., Castagnola E. 2017. Candida infections in paediatrics: results from a prospective single-centre study in a tertiary care children’s hospital. Mycoses 60: 118-123. doi:10.1111/myc.12570
• [12] Meersseman W., Lagrou K., Spriet I., Maertens J., Verbeken E., Peetermans W.E., Van Wijngaerden E. 2009. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Medicine 35: 1526-1531. doi:10.1007/s00134-009-1482-8
• [13] Bruyère R., Quenot J.-P., Prin S., Dalle F., Vigneron C., Aho S., Leon C., Charles P.-E. 2014. Empirical antifungal therapy with an echinocandin in criticallyill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU. BMC Infectious Diseases 14: 385. doi:10.1186/1471-2334-14-385
• [14] Zilberberg M., Yu H.-T., Chaudhari P., Emons M.F., Khandelwal N., Shorr A.F. 2014. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study. Critical Care 18: 590. doi:10.1186/s13054-014-0590-1
• [15] Pfaller M.A., Diekema D.J. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clinical Microbiology Reviews 20: 133-163. doi:10.1128/cmr.00029-06
• [16] Cleveland A.A., Farley M.M., Harrison L.H., Stein B., Hollick R., Lockhart S.R., Magill S.S., Derado G., Park B.J., Chiller T.M. 2012. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clinical Infectious Diseases 55: 1352-1361. https://doi.org/10.1093/cid/cis697
• [17] Lockhart S.R., Iqbal N., Cleveland A.A., Farley M.M., Harrison L.H., Bolden C.B., Baughman W., Stein B., Hollick R., Park B.J., Chiller T. 2012. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. Journal of Clinical Microbiology 50: 3435-3442. doi:10.1128/jcm.01283-12
• [18] Guinea J. 2014. Global trends in the distribution of Candida species causing candidemia. Clinical Microbiology and Infection 20 (Suppl. 6): 5-10. http://dx.doi.org/10.1111/1469-0691.12539
• [19] Das I., Nightingale P., Patel M., Jumaa P. 2011. Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK. International Journal of Infectious Diseases 15: e759-e763. http://dx.doi.org/10.1016/j.ijid.2011.06.006
• [20] Tan B.H., Chakrabarti A., Li R.Y., Patel A.K., Watcharananan S.P., Liu Z., Chindamporn A., Tan A.L., Sun P.-L., Wu U.-I., Chen Y.-C., Asia Fungal Working Group (AFWG). 2015. Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clinical Microbiology and Infection 21: 946-953. http://dx.doi.org/10.1016/j.cmi.2015.06.010
• [21] Gupta A., Gupta A., Varma A. 2015. Candida glabrata candidemia: an emerging threat in critically ill patients. Indian Journal of Critical Care Medicine 19: 151-154. doi:10.4103/0972-5229.152757
• [22] Kurnatowska A.K., Kwaśniewska J. 2009. Wrażliwość na mikonazol i itrakonazol szczepów grzybów z rodzaju Candida wyodrębnionych od pacjentów hospitalizowanych i leczonych w trybie ambulatoryjnym [Susceptibility to miconazole and itraconazole of Candida strains isolated from hospitalized and outpatient clinic patients]. Wiadomości Parazytologiczne 55: 415-423 (in Polish with summary in English).
• [23] Chakrabarti A., Sood P., Rudramurthy S.M., Chen S., Kaur H., Capoor M., Chhina D., Rao R., Eshwara V.K., Xess I., Kindo A.J., Umabala P.., Savio J., Patel A., Ray U., Mohan S., Iyer R., Chander J., Arora A., Sardana R., Roy I., Appalaraju B., Sharma A., Shetty A., Khanna N., Marak R., Biswas S., Das S., Harish B.N., Joshi S., Mendiratta D. 2015. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Medicine 41: 285-295. doi:10.1007/s00134-014-3603-2
• [24] Modrzewska B., Kurnatowska A. 2010. Różnicowanie wewnątrzgatunkowe szczepów Candida albicans (Robin, 1853) Berkhout, 1923 z inwazji wieloogniskowych – parametry ich identyczności lub podobieństwa [Interspecies differentiation of Candida albicans (Robin, 1853) Berkhout, 1923 strains from multifocal invasions – their identity or similarity parameters]. Wiadomości Para zyto logiczne 56: 253-268 (in Polish with summary in English).
• [25] Kuba K., Gortat K., Kurnatowski P. 2011. Różnicowanie gatunków rodzaju Candida (Robin, 1853) Berkhout 1923, wyodrębnionych od osób z chorobami dolnych dróg oddechowych [The differentiation of Candida species (Robin, 1853) Berkhout 1923 isolated from persons with diseases of the lower airways]. Mikologia Lekarska 18: 125-130 (in Polish with summary in English).
• [26] Modrzewska B. 2013. Porównanie właściwości różnych gatunków z rodzaju Candida pochodzących od pacjentów leczonych ambulatoryjnie i hospitalizowanych [Comparison of properties of various Candida species derived from patients treated in hospitals and outpatient clinics]. Ph.D. dissertation, Department of Biology and Parasitology, Medical University of Lodz, Poland (in Polish with summary in English).
• [27] Głowacka A. 2002. Ustalenie łańcucha epidemiologicznego dermatomikoz w wybranych Wyższych Seminariach Zakonnym i Duchownym Archidiecezji Łódzkiej. Część II. Zastosowanie zasady numerycznej identyfikacji i genotypowania do określenia podobieństwa między szczepamigrzybów Candida albicans wyizolowanych z powierzchni krat urządzeń sanitarnych i zmian chorobowych skóry przestrzeni międzypalcowych i wałów okołopaznokciowych stóp u seminarzystów [Assignation of the epidemiological chain of dermatomycoses in selected Monastic and Ecclesiastic Theological Seminaries among the area of Lodz Archdiocese. Part II. Application of numeric identification rule and genotyping in order to determine similarity between Candida albicans strains isolated from the surface of gratings from sanitation and skin lesions of interdigital spaces of feet and walls of toe nails in seminarists]. Mikologia Lekarska 9: 199-207 (in Polish with summary in English).
• [28] Biernasiuk A., Korona-Głowniak I., Mahorowska-Kiciak I., Rybojad P., Malm A. 2006. Pharyngeal Candida sp. strains in patients with non-small cell lung cancer. Mikologia Lekarska 13: 89-93.
• [29] Ogrodziński M. J., Kurnatowska A. 2007. Prewalencja oraz cechy fenotypowe grzybów wyodrębnionych z narządów płciowych kobiet w badaniach przesiewowych i klinicznych w regionie Pomorsko-Drawskim [Prevalence and phenotypic features of fungi isolated from female sexual organs in screening and clinical studies of the Pomorsko-Drawski Region]. Mikologia Lekarska 14: 190-194 (in Polish with summary in English).
• [30] Gaspar G.G., Menegueti M.G., Auxiliadora-Martins M., Basile-Filho A., Martinez R. 2015. Evaluation of the predictive indices for candidemia in an adult intensive care unit. Revista da Sociedade Brasileira de Medicina Tropical 48: 77-82. http://dx.doi.org/10.1590/0037-8682-0292-2014
• [31] Mensa J., Pitart C., Marco F. 2008. Treatment of critically ill patients with candidemia. International Journal of Antimicrobial Agents 32 (Suppl. 2): S93-S97. http://dx.doi.org/10.1016/s0924-8579(08)70007-4
• [32] Garnacho-Montero J., Díaz-Martín A., Cayuela-Dominguez A. 2008. Management of invasive Candida infections in non-neutropenic critically ill patients: from prophylaxis to early therapy. International Journal of Antimicrobial Agents 32 (Suppl. 2): S137-S141. http://dx.doi.org/10.1016/s0924-8579(08)70015-3
• [33] Chakrabarti A. 2015. Candida glabrata candidemia. Indian Journal of Critical Care Medicine 19: 138-139. doi:10.4103/0972-5229.152753
• [34] Tyczkowska-Sieron E., Gaszynski W., Tyczkowski J., Glowacka A. 2014. Analysis of the relationship between fluconazole consumption and non-C. albicans Candida infections. Medical Mycology 52: 758-765. https://doi.org/10.1093/mmy/myu053
• [35] Almirante B., Rodríguez D., Park B.J., Cuenca-Estrella M., Planes A.M., Almela M., Mensa J., Sanchez F., Ayats J., Gimenez M., Saballs P., Fridkin S.K., Morgan J., Rodriguez-Tudela J.L., Warnock D.W., Pahissa A., Barcelona Candidemia Project Study Group. 2005. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. Journal of Clinical Microbiology 43: 1829-1835. doi:10.1128/jcm.43.4.1829-1835.2005
• [36] Vardakas K.Z., Samonis G., Michalopoulos A., Soteriades E.S., Falagas M.E. 2006. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Critical Care Medicine 34: 1216-1224. doi:10.1097/01.ccm.0000208357.05675.c3
• [37] Shorr A.F., Chung K., Jackson W.L., Waterman P.E., Kollef M.H. 2005. Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Critical Care Medicine 33: 1928-1935. doi:10.1097/01.ccm.0000178352.14703.49
• [38] Playford E.G., Webster A.C., Sorrell T.C., Craig J.C. 2006. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and metaanalysis of randomized clinical trials. Journal of Antimicrobial Chemotherapy 57: 628-638. https://doi.org/10.1093/jac/dki491

Identyfikatory

DOI

10.17420/ap6303.105